The epidemic of antibiotic-resistant infections: A call to action for the medical community from the Infectious Diseases Society of America

被引:1174
作者
Spellberg, Brad [1 ,2 ]
Guidos, Robert [5 ]
Gilbert, David [7 ,8 ]
Bradley, John [3 ,4 ]
Boucher, Helen W. [9 ]
Scheld, W. Michael [6 ]
Bartlett, John G. [10 ]
Edwards, John, Jr. [1 ,2 ]
机构
[1] Harbor UCLA Med Ctr, Div Infect Dis, Torrance, CA 90502 USA
[2] Univ Calif Los Angeles, Geffen Sch Med, Los Angeles, CA USA
[3] Childrens Hosp San Diego, San Diego, CA USA
[4] Univ Calif San Diego, La Jolla, CA 92093 USA
[5] Infect Dis Soc Amer, Alexandria, VA 22314 USA
[6] Univ Virginia Hlth Syst, Div Infect Dis, Charlottesville, VA USA
[7] Providence Portland Med Ctr, Div Infect Dis, Portland, OR USA
[8] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[9] Tufts Univ New England Med Ctr, Boston, MA USA
[10] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
关键词
D O I
10.1086/524891
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ongoing explosion of antibiotic-resistant infections continues to plague global and US health care. Meanwhile, an equally alarming decline has occurred in the research and development of new antibiotics to deal with the threat. In response to this microbial "perfect storm," in 2001, the federal Interagency Task Force on Antimicrobial Resistance released the " Action Plan to Combat Antimicrobial Resistance; Part 1: Domestic" to strengthen the response in the United States. The Infectious Diseases Society of America (IDSA) followed in 2004 with its own report, " Bad Bugs, No Drugs: As Antibiotic Discovery Stagnates, A Public Health Crisis Brews," which proposed incentives to reinvigorate pharmaceutical investment in antibiotic research and development. The IDSA's subsequent lobbying efforts led to the introduction of promising legislation in the 109th US Congress ( January 2005-December 2006). Unfortunately, the legislation was not enacted. During the 110th Congress, the IDSA has continued to work with congressional leaders on promising legislation to address antibiotic-resistant infection. Nevertheless, despite intensive public relations and lobbying efforts, it remains unclear whether sufficiently robust legislation will be enacted. In the meantime, microbes continue to become more resistant, the antibiotic pipeline continues to diminish, and the majority of the public remains unaware of this critical situation. The result of insufficient federal funding; insufficient surveillance, prevention, and control; insufficient research and development activities; misguided regulation of antibiotics in agriculture and, in particular, for food animals; and insufficient overall coordination of US ( and international) efforts could mean a literal return to the preantibiotic era for many types of infections. If we are to address the antimicrobial resistance crisis, a concerted, grassroots effort led by the medical community will be required.
引用
收藏
页码:155 / 164
页数:10
相关论文
共 82 条
[1]   Resistance to antibiotics: Are we in the post-antibiotic era? [J].
Alanis, AJ .
ARCHIVES OF MEDICAL RESEARCH, 2005, 36 (06) :697-705
[2]   Archean microfossils: a reappraisal of early life on Earth [J].
Altermann, W ;
Kazmierczak, J .
RESEARCH IN MICROBIOLOGY, 2003, 154 (09) :611-617
[3]  
Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P741
[4]  
[Anonymous], 2002, WORLD HLTH REP
[5]  
[Anonymous], 2004, MICROBIOLOGY 21 CENT
[6]  
[Anonymous], BAD BUGS DRUGS ANT D
[7]   The indigenous gastrointestinal microflora [J].
Berg, RD .
TRENDS IN MICROBIOLOGY, 1996, 4 (11) :430-435
[8]  
BJERKLIE D, 2006, TIME
[9]  
BLASER M, 2006, BIOTERRORISM PUBLIC
[10]  
BLASER MJ, 2006, LETT FDA COMMISSIONE